Endonovo Therapeutics Announces Immunotronic and Cytotronic Platforms
Bioelectronics-Based Platforms Seek to Address Inflammatory Conditions in Vital Organs, Including Acute Organ Failure and Cell/Tissue Engineering LOS ANGELES, CA - (NewMediaWire) - October 06, 2015 - Endonovo Therapeutics, Inc. (OTCQB: ENDV) (" …